KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Neogenomics (NEO) Assets Average: 2009-2025

Historic Assets Average for Neogenomics (NEO) over the last 15 years, with Sep 2025 value amounting to $1.4 billion.

  • Neogenomics' Assets Average fell 15.70% to $1.4 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 billion, marking a year-over-year decrease of 15.70%. This contributed to the annual value of $1.7 billion for FY2024, which is 2.98% down from last year.
  • As of Q3 2025, Neogenomics' Assets Average stood at $1.4 billion, which was down 7.57% from $1.5 billion recorded in Q2 2025.
  • In the past 5 years, Neogenomics' Assets Average registered a high of $1.9 billion during Q3 2021, and its lowest value of $762.0 million during Q1 2021.
  • Its 3-year average for Assets Average is $1.6 billion, with a median of $1.6 billion in 2024.
  • Per our database at Business Quant, Neogenomics' Assets Average spiked by 281.81% in 2021 and then decreased by 15.70% in 2025.
  • Neogenomics' Assets Average (Quarterly) stood at $1.9 billion in 2021, then dropped by 7.43% to $1.7 billion in 2022, then dropped by 3.89% to $1.7 billion in 2023, then decreased by 2.39% to $1.6 billion in 2024, then fell by 15.70% to $1.4 billion in 2025.
  • Its Assets Average was $1.4 billion in Q3 2025, compared to $1.5 billion in Q2 2025 and $1.6 billion in Q1 2025.